Literature DB >> 32841826

Prevalence of suicidal ideation and suicide attempt in patients with migraine: A systematic review and meta-analysis.

Ju-Hong Pei1, Xing-Lei Wang2, Yang Yu3, Ya-Bin Zhang1, Lin Gou1, Rui-Ling Nan4, Hai-Xia Chen1, Xin-Man Dou5, Zhi-Jian Han6.   

Abstract

BACKGROUND: Suicidality is common in patients with migraine. Here, we performed a systematic review and estimated the prevalence of suicidal ideation (SI) and suicide attempt (SA) in patients with migraine.
METHODS: We searched Pubmed, Embase, Web of Science, Cochrane database library, CINAHL, and PsycINFO for relevant publications. A random-effects model was used to pool the estimates of the prevalence of SI and SA, which were also stratified by the geographical location of the research institutions from the studies included in this meta-analysis.
RESULTS: Fifteen studies involving 2,247,648 participants with migraine were selected. Pooled prevalence estimates of SI and SA were 15.5% [95% confidence interval (CI) 10.4-21.3%] and 3.9% (95% CI 0.9-8.8%), respectively, and the prevalence of SI was higher in Asian countries (21.5%, 95%CI 16.8-26.6%) compared with non-Asian countries (11.0%, 95%CI 6.1-17.2%). Measures of heterogeneity between studies were high for all outcomes (I2 = 89-100%), indicating that the substantial between-study heterogeneity in estimated proportions was not attributed to sampling error. The leave-one-out analysis showed that no single study significantly affected the final pooled results.
CONCLUSIONS: This meta-analysis indicated a high prevalence of SI and SA in migraine patients. Thus, it is necessary to design targeted preventive measures for the management of migraine-related suicide.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Meta-analysis; Migraine; Suicidal ideation; Suicide attempt

Year:  2020        PMID: 32841826     DOI: 10.1016/j.jad.2020.08.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Health-related quality of life and associated factors in Chinese menstrual migraine patients: a cross-sectional study.

Authors:  Wenxiu Luo; Xing Cao; Jiayu Zhao; Jiaming Yang; Yu Cen; Jinlong He; Jing Luo; Yunling Zhong; Ying Luo; Xinyue Wang; Liqiu Yang; Xingyu Feng; Xiaoqing Pang; Jiazhu Zhang; Jiaming Luo
Journal:  BMC Womens Health       Date:  2022-05-15       Impact factor: 2.742

2.  Headache disability, lifestyle factors, health perception, and mental disorder symptoms: a cross-sectional analysis of the 2013 National Health Survey in Brazil.

Authors:  Arão Belitardo de Oliveira; Juliane Prieto Peres Mercante; Isabela M Benseñor; Alessandra C Goulart; Mario Fernando Prieto Peres
Journal:  Neurol Sci       Date:  2021-09-24       Impact factor: 3.307

3.  Demoralization predicts suicidality in patients with cluster headache.

Authors:  Brian B Koo; Ahmed Bayoumi; Abdalla Albanna; Mohammed Abusuliman; Laura Burrone; Jason J Sico; Emmanuelle A D Schindler
Journal:  J Headache Pain       Date:  2021-04-20       Impact factor: 7.277

4.  Self-Reported Pain and Emotional Reactivity in Bipolar Disorder: A Prospective FACE-BD Study.

Authors:  Nathan Risch; Jonathan Dubois; Katia M'bailara; Irena Cussac; Bruno Etain; Raoul Belzeaux; Caroline Dubertret; Emmanuel Haffen; Raymund Schwan; Ludovic Samalin; Paul Roux; Mircea Polosan; Marion Leboyer; Philippe Courtet; Emilie Olié
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

5.  Suicide Attempts in US Veterans with Chronic Headache Disorders: A 10-Year Retrospective Cohort Study.

Authors:  X Michelle Androulakis; Siyuan Guo; Jiajia Zhang; Jason Sico; Peter Warren; Alec Giakas; Xiaoming Li; B Lee Peterlin; Roy Mathew; Deborah Reyes
Journal:  J Pain Res       Date:  2021-08-24       Impact factor: 3.133

6.  Psychosocial Variables and Healthcare Resources in Patients with Fibromyalgia, Migraine and Comorbid Fibromyalgia and Migraine: A Cross-Sectional Study.

Authors:  Elena P Calandre; Juan M García-Leiva; Jorge L Ordoñez-Carrasco
Journal:  Int J Environ Res Public Health       Date:  2022-07-23       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.